Identification of serum metabolic traits of AIWG in first-episode schizophrenia patients
Abstract Background Antipsychotic-induced weight gain (AIWG) is a common side effect of antipsychotic drugs and may lead to cardiometabolic comorbidities. There is an urgent public health need to identify patients at high risk of AIWG and determine potential biomarkers for AIWG. Methods In the Seque...
Saved in:
Main Authors: | Suzhen Zhang, Zhaolin Zhai, Tianhao Gao, Xinping Kuai, Xuan Li, Yuke Dong, Chang Lu, Kaiming Zhuo, Qiong Xiang, Dengtang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-024-06413-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of factors associated with obesity in patients using antipsychotics in schizophrenia
by: Vishalakshi Patnam, et al.
Published: (2024-12-01) -
Involuntary medication treatment of schizophrenia in the inpatient setting
by: Courtney A. Iuppa, PharmD, BCPP
Published: (2024-12-01) -
Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?
by: Ita Fitzgerald, et al.
Published: (2024-11-01) -
Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
by: Mulualem Kelebie, et al.
Published: (2025-02-01) -
Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study
by: Ramandeep Kaur, et al.
Published: (2023-04-01)